- Home
- ADVB vs LGVN Comparison
ADVB vs LGVN Comparison
Compare ADVB & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- LGVN
- Stock Information
- Founded
- ADVB 2014
- LGVN 2014
- Country
- ADVB United States
- LGVN United States
- Employees
- ADVB N/A
- LGVN N/A
- Industry
- ADVB Medical Specialities
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- ADVB Health Care
- LGVN Health Care
- Exchange
- ADVB Nasdaq
- LGVN Nasdaq
- Market Cap
- ADVB 20.8M
- LGVN 23.4M
- IPO Year
- ADVB 2025
- LGVN 2021
- Fundamental
- Price
- ADVB $0.53
- LGVN $1.64
- Analyst Decision
- ADVB
- LGVN Strong Buy
- Analyst Count
- ADVB 0
- LGVN 3
- Target Price
- ADVB N/A
- LGVN $8.67
- AVG Volume (30 Days)
- ADVB 223.6K
- LGVN 827.1K
- Earning Date
- ADVB 08-03-2025
- LGVN 08-13-2025
- Dividend Yield
- ADVB N/A
- LGVN N/A
- EPS Growth
- ADVB N/A
- LGVN N/A
- EPS
- ADVB N/A
- LGVN N/A
- Revenue
- ADVB N/A
- LGVN $2,225,000.00
- Revenue This Year
- ADVB N/A
- LGVN N/A
- Revenue Next Year
- ADVB N/A
- LGVN $51.48
- P/E Ratio
- ADVB N/A
- LGVN N/A
- Revenue Growth
- ADVB N/A
- LGVN 127.50
- 52 Week Low
- ADVB $0.46
- LGVN $1.14
- 52 Week High
- ADVB $4.10
- LGVN $4.29
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- LGVN 60.49
- Support Level
- ADVB N/A
- LGVN $1.43
- Resistance Level
- ADVB N/A
- LGVN $1.80
- Average True Range (ATR)
- ADVB 0.00
- LGVN 0.13
- MACD
- ADVB 0.00
- LGVN 0.02
- Stochastic Oscillator
- ADVB 0.00
- LGVN 63.22
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.